Article: FDA Approved ROZEREM(TM) (ramelteon), First and Only Non-Scheduled Prescription Sleep Medication.

Article: ROZEREM(TM) (ramelteon) Showed Significant Reduction in ...
PR Newswire;  April 3, 2006 ;     700+ words ... ... discontinuation of treatment with ROZEREM. Rebound insomnia is the worsening of insomnia ... percentage of adults with chronic insomnia treated with ROZEREM 8 mg demonstrated at least ... option for the treatment of insomnia." ROZEREM is the first and only prescription ...

Article: Study Demonstrated ROZEREM(TM) (ramelteon) Does Not Affect ...
PR Newswire;  June 13, 2007 ;     700+ words ... ... adults with chronic insomnia received ROZEREM 8 mg, zopiclone ... older with chronic insomnia received ROZEREM 8 mg, zolpidem 10 ... the treatment of insomnia characterized by ... with sleep onset. ROZEREM can be prescribed ...

Article: Takeda won FDA approval to market Rozerem (ramelteon), 8 ...
Medical Marketing & Media;  September 1, 2005 ;     385 words ...Takeda won FDA approval to market Rozerem (ramelteon), 8 mg. tablets for the treatment of insomnia. Rozerem is the only prescription sleep medication not designated as a controlled substance by the U.S. Drug Enforcement Administration.

Article: Rozerem shows efficacy as transient insomnia ...
Pharma Marketletter;  June 26, 2006 ;     700+ words ... ... meeting of the Associated Professional Sleep Societies shows that Rozerem (ramelton), under development by Takeda Pharmaceuticals ... study, which utilized a first-night-model of transient insomnia, enrolled 289 patients who were randomized to receive 8mg ...

Article: Unfavorable Tier Placement Makes Safer Insomnia Drug, ...
PR Newswire;  October 16, 2006 ;     700+ words ... ... safety profile, Takeda's Rozerem (ramelteon), the first ... approved for treating insomnia, faces enormous hurdles ... care physicians select Rozerem as a first-line agent for primary, chronic insomnia, more than 60% of primary ...

Article: Rozerem gets FDA approval as treatment for ...
Chain Drug Review;  August 29, 2005 ;     669 words ...The Food and Drug Administration has approved a new insomnia treatment. Manufacturer Takeda Pharmaceuticals Inc. says the product, Rozerem, the first prescription sleep aid not designated as a controlled substance, will be available late next ...

Article: Takeda's Rozerem positive in older patients with ...
Pharma Marketletter;  June 25, 2007 ;     700+ words ... ... Japanese drug major Takeda's Rozerem (ramelteon) did not affect ... who suffer from chronic insomnia. "These data are important because they show that Rozerem may be a safe sleep medication ... memories were not affected by Rozerem the next morning," said ...